Revenio Group Corporation: REVENIO AIMS TO LAUNCH SCREENING

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jan 21, 2015 at 2:15 AM

Revenio Group Corporation: REVENIO AIMS TO LAUNCH SCREENING DEVICE TO DETECT SKIN CANCER

Revenio Group Corporation Stock Exchange Release, January 21, 2015 at 9:00 am REVENIO AIMS TO LAUNCH SCREENING DEVICE TO DETECT SKIN CANCER Revenio to cooperate with VTT Technical Research Centre of Finland and University of Jyväskylä to commercialize technology for skin cancer screening The Revenio Group Corporation has signed a license agreement with VTT Technical Research Centre of Finland concerning intellectual property rights and know-how regarding the hyperspectral camera technology developed by VTT. Under the agreement, Revenio will license the technology, know-how, documentation, software, inventions and associated patent rights relating to VTT's hyperspectral camera. Revenio has also signed a cooperation agreement with VTT on commercialization of a hyperspectral imaging system suitable for skin cancer diagnostics and with the University of Jyväskylä on commercialization of the invention relating to the software code. During 2015, Revenio and VTT will develop second generation prototypes of the hyperspectral camera. The final schedule for the project will become clearer in the light of experience gained. Revenio aims to launch an easy-to-use, mobile screening device for dermatologists to use to detect skin cancers and their precursors. According to the company's current view, the screening device is not expected to generate significant commercial value for a few years. "The license agreement we have signed will provide us with an opportunity to make an easy-to-use, mobile screening device to detect skin changes at an early stage available to dermatologists quickly and cost-effectively. Once again we are dealing with issues that are important to us - improving the quality of people's lives and lowering the costs of health care. At Revenio, we will continue to focus on our current range of products, in line with our strategy, and increasingly on screening-related products. With these products we aim to meet global public health challenges where common denominators are the need to make cost savings in health care through preventive measures. Screening and follow-up hold a significant role in preventive work and it is here that we want to play a key role," says the Revenio Group's President and CEO Olli-Pekka Salovaara. "VTT has developed the adjustable filter technology determinedly for a number of years now. It has an extremely wide range of use in various measurement and imaging applications and business operations have already developed around the technology. The cooperation with Revenio will open up wider possibilities for using the method in health tech applications - also an important growth area for VTT. This is a good example of how Finnish businesses can be created through VTT's technology," comments Petri Kalliokoski, Executive Vice President, Knowledge Intensive Products and Services. The basic invention, a spectral imaging device made up of a so-called Fabry- Pérot filter and a camera, was developed by Heikki Saari, Principal Scientist at VTT, some ten years ago and it has numerous different potential applications. VTT developed the hyperspectral camera which utilizes the technology to detect skin changes caused by skin cancer on the basis of an idea of Professor Pekka Neittaanmäki. The first generation prototypes of the hyperspectral camera have been in trial use at the dermatology department of a Finnish hospital for over a year, and the results are very encouraging. The prototype has already received a great deal of publicity in Finland, with the technology magazine Tekniikan Maailma (No.11/2014) and the Finnish daily Helsingin Sanomat (October 10, 2014) featuring articles on the technology. Skin cancers and their precursors are increasingly rapidly throughout the world. The underlying cause of various skin changes lies in continuously increasing exposure to UV radiation. The earlier skin cancer is detected, the lower the mortality rate and costs incurred to society. Revenio Group Corporation Olli-Pekka Salovaara President & CEO For additional information, please contact President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi http://www.revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media http://www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business lies in screening. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening, monitoring and diagnosis. In addition, Revenio has identified new growth opportunities relating to health tech in which common denominators are screening, follow-up and the global need to make cost savings in health care through preventive measures. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. In 2013, the Revenio Group's net sales totaled MEUR 25.7, with its operating margin standing at 21.7%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1888493]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truck Drivers USA & Career Driver Unveil New Driver Agent

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Gourmia Introduces Ceramic-Coated Air Fryer at Costco

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Oracle Announces AI-Driven QuickStart Platform Launch

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Omega Point's MCP Secures Anthropic Verification

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

xFusion Tackles Cooling and Power at OCP 2026

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Cogent Communications' Q3 2026 Earnings Call Details

Cue the Countdown: Cogent’s Earnings Call Looms Another quarter rolls by, and with it comes Cogent Communications' chance to strut—or stumble—before the crowd. Their third-quarter earnings call on November 5, 2026, is like the opening bell for a stock that's zipped through more ups and downs than a tired bullfighter's routine. What the call reveals on that crisp...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....